6 min read
Artificial intelligence is being used in healthcare for everything from answering patient questions to assisting with surgeries and developing new pharmaceuticals.
According to Statista (link resides outside ibm.com), the artificial intelligence (AI) healthcare market, which is valued at USD 11 billion in 2021, is projected to be worth USD 187 billion in 2030. That massive increase means we will likely continue to see considerable changes in how medical providers, hospitals, pharmaceutical and biotechnology companies, and others in the healthcare industry operate.
Better machine learning (ML) algorithms, more access to data, cheaper hardware, and the availability of 5G have contributed to the increasing application of AI in the healthcare industry, accelerating the pace of change. AI and ML technologies can sift through enormous volumes of health data—from health records and clinical studies to genetic information—and analyze it much faster than humans.
Healthcare organizations are using AI to improve the efficiency of all kinds of processes, from back-office tasks to patient care. The following are some examples of how AI might be used to benefit staff and patients:
A recent study found that 83% of patients report poor communication as the worst part of their experience, demonstrating a strong need for clearer communication between patients and providers.
AI technologies like natural language processing (NLP), predictive analytics, and speech recognition might help healthcare providers have more effective communication with patients. AI might, for instance, deliver more specific information about a patient’s treatment options, allowing the healthcare provider to have more meaningful conversations with the patient for shared decision-making.
According to Harvard’s School of Public Health (link resides outside ibm.com), although it’s early days for this use, using AI to make diagnoses may reduce treatment costs by up to 50% and improve health outcomes by 40%.
One use case example is out of the University of Hawaii (link resides outside ibm.com), where a research team found that deploying deep learning AI technology can improve breast cancer risk prediction. More research is needed, but the lead researcher pointed out that an AI algorithm can be trained on a much larger set of images than a radiologist—as many as a million or more radiology images. Also, that algorithm can be replicated at no cost except for hardware.
An MIT group (link resides outside ibm.com) developed an ML algorithm to determine when a human expert is needed. In some instances, such as identifying cardiomegaly in chest X-rays, they found that a hybrid human-AI model produced the best results.
Another published study (link resides outside ibm.com) found that AI recognized skin cancer better than experienced doctors. US, German and French researchers used deep learning on more than 100,000 images to identify skin cancer. Comparing the results of AI to those of 58 international dermatologists, they found AI did better.
As health and fitness monitors become more popular and more people use apps that track and analyze details about their health. They can share these real-time data sets with their doctors to monitor health issues and provide alerts in case of problems.
AI solutions—such as big data applications, machine learning algorithms and deep learning algorithms—might also be used to help humans analyze large data sets to help clinical and other decision-making. AI might also be used to help detect and track infectious diseases, such as COVID-19, tuberculosis, and malaria.
One benefit the use of AI brings to health systems is making gathering and sharing information easier. AI can help providers keep track of patient data more efficiently.
One example is diabetes. According to the Centers for Disease Control and Prevention (link resides outside ibm.com), 11.6% of the US population has diabetes. Patients can now use wearable and other monitoring devices that provide feedback about their glucose levels to themselves and their medical team.
AI can help providers gather that information, store, and analyze it, and provide data-driven insights from vast numbers of people. Using this information can help healthcare professionals determine how to better treat and manage diseases.
Organizations are also starting to use AI to help improve drug safety. The company SELTA SQUARE, for example, is innovating the pharmacovigilance (PV) process, a legally mandated discipline for detecting and reporting adverse effects from drugs, then assessing, understanding, and preventing those effects.
PV demands significant effort and diligence from pharma producers because it’s performed from the clinical trials phase all the way through the drug’s lifetime availability. Selta Square uses a combination of AI and automation to make the PV process faster and more accurate, which helps make medicines safer for people worldwide.
Sometimes, AI might reduce the need to test potential drug compounds physically, which is an enormous cost-savings. High-fidelity molecular simulations (link resides outside ibm.com) can run on computers without incurring the high costs of traditional discovery methods.
AI also has the potential to help humans predict toxicity, bioactivity, and other characteristics of molecules or create previously unknown drug molecules from scratch.
As AI becomes more important in healthcare delivery and more AI medical applications are developed, ethical, and regulatory governance must be established. Issues that raise concern include the possibility of bias, lack of transparency, privacy concerns regarding data used for training AI models, and safety and liability issues.
“AI governance is necessary, especially for clinical applications of the technology,” said Laura Craft, VP Analyst at Gartner (link resides outside ibm.com). “However, because new AI techniques are largely new territory for most [health delivery organizations], there is a lack of common rules, processes, and guidelines for eager entrepreneurs to follow as they design their pilots.”
The World Health Organization (WHO) spent 18 months deliberating with leading experts in ethics, digital technology, law, and human rights and various Ministries of Health members to produce a report that is called Ethics & Governance of Artificial Intelligence for Health (link resides outside ibm.com). This report identifies ethical challenges to using AI in healthcare, identifies risks, and outlines six consensus principles (link resides outside ibm.com) to ensure AI works for the public’s benefit:
The WHO report also provides recommendations that ensure governing AI for healthcare both maximizes the technology’s promise and holds healthcare workers accountable and responsive to the communities and people they work with.
AI provides opportunities to help reduce human error, assist medical professionals and staff, and provide patient services 24/7. As AI tools continue to develop, there is potential to use AI even more in reading medical images, X-rays and scans, diagnosing medical problems and creating treatment plans.
AI applications continue to help streamline various tasks, from answering phones to analyzing population health trends (and likely, applications yet to be considered). For instance, future AI tools may automate or augment more of the work of clinicians and staff members. That will free up humans to spend more time on more effective and compassionate face-to-face professional care.
When patients need help, they don’t want to (or can’t) wait on hold. Healthcare facilities’ resources are finite, so help isn’t always available instantaneously or 24/7—and even slight delays can create frustration and feelings of isolation or cause certain conditions to worsen.
IBM watsonx™ Assistant AI healthcare chatbots can help providers do two things: keep their time focused where it needs to be and empower patients who call in to get quick answers to simple questions.
IBM watsonx Assistant is built on deep learning, machine learning and natural language processing (NLP) models to understand questions, search for the best answers and complete transactions by using conversational AI.
Subscribe to the Think Newsletter
We surveyed 2,000 organizations about their AI initiatives to discover what's working, what's not and how you can get ahead.
IBM® Granite™ is our family of open, performant and trusted AI models, tailored for business and optimized to scale your AI applications. Explore language, code, time series and guardrail options.
Access our full catalog of over 100 online courses by purchasing an individual or multi-user subscription today, enabling you to expand your skills across a range of our products at one low price.
Led by top IBM thought leaders, the curriculum is designed to help business leaders gain the knowledge needed to prioritize the AI investments that can drive growth.
Want to get a better return on your AI investments? Learn how scaling gen AI in key areas drives change by helping your best minds build and deliver innovative new solutions.
Learn how to confidently incorporate generative AI and machine learning into your business.
Dive into the 3 critical elements of a strong AI strategy: creating a competitive edge, scaling AI across the business and advancing trustworthy AI.